Digestibility and utilization of pearl millet diets fed to finishing beef cattle.

Pearl millet grain was blended with corn in 1:1 or 2:1 ratios in beef finishing diets fed in two metabolism and two feedlot trials. In Exp. 1, diets contained 1) 79.5% corn and 4.5% soybean meal (C-SBM), 2) 28% corn, 54.5% sorghum, and 1.5% soybean meal [GSC(2:1)], and 3) 28% corn and 56% pearl millet [PMC(2:1)]. In Exp. 2, diets contained 1) 81.5% corn and 3.5% soybean meal (C-SBM) or 2) 42.5% corn and 42.5% pearl millet [PMC(1:1)]. Diets fed to steers in metabolism trials in Exp. 1 and 2 had similar (P > .10) apparent digestion coefficients for OM, crude fiber, NDF, and ADF. However, ether extract digestibility was higher (P < .05) for C-SBM than for GSC(2:1) and PMC(2:1) in Exp. 1, and it was higher (P < .10) for C-SBM than for PMC(1:1) in Exp. 2. In both experiments CP digestibility was higher (P < .10) for C-SBM diets, and N retention was similar (P > .10) for diets within each experiment. In each experiment, TDN calculated from apparent digestion coefficients was converted to NEm and NEg. The TDN, NEm, and NEg were lower (P < .10) for GSC(2:1) and PMC(2:1) than for C-SBM in Exp. 1. Experimental diets were fed to steers (n = 45; 396 +/- 19 kg initial BW; 70-d ad libitum feeding) in Exp. 1 and to heifers (n = 30; 318 +/- 15 kg initial BW; 92-d ad libitum feeding) in Exp. 2. The ADG, empty body weight gain (EBG), and predicted EBG were not different (P > .10) for diets composed of the different grain sources. Feed DMI and DM per gain were higher (P < .05) for PMC(1:1) than for C-SBM in Exp. 2. Pearl millet supplied approximately 88% as much NEm and 85% as much NEg as the corn-SBM portion of diets having similar CP concentrations.

Effect of supplemental fish meal protein on site and extent of digestion in beef steers.

The effects of supplemental fish meal on site and extent of digestion were determined using four steers equipped with ruminal, duodenal, and ileal cannulas. Fish meal was included in diets to supply 0 (0FM), 25 (25FM), 50 (50FM), or 75 (75FM) g of N daily above the CP requirement of a 400-kg steer gaining 1.2 kg/d. Total tract starch digestibility tended to be greatest for 25FM (95%), lowest for 0FM (90%), and intermediate for 50FM (94%) and 75FM (92%). Total tract N digestibility was greatest for 25FM, lowest for 0FM, and intermediate for 50FM and 75FM (cubic, P < .05). Total tract starch digestibility increased .46 percentage units for each unit increase in N digestibility (n = 16, P = .03). Ruminal starch digestibility was greatest for 25FM, intermediate for 50FM and 75FM, and lowest for 0FM (quadratic; P < .10). Starch flow to the duodenum was decreased for 25FM and 50FM vs 0FM and 75FM (quadratic, P < .10) and N flow to the duodenum was increased (linear, P < .01) by fish meal. Fish meal supplementation increased N digestibility (quadratic, P < .05) but had no effect (P > .10) on starch digestibility in the small intestine. Starch digestibility in the small intestine was not related to N flow to the duodenum; however, starch digestibility increased .9 percentage units for each percentage unit increase in N digestibility (n = 16, P = .02). Fish meal supplementation tended to increase total tract starch digestibility by increasing ruminal, but not small intestinal, digestibility.

Vitamin E supplementation and the retinopathy of prematurity.

The effect of high-dosage E treatment (Rx) initiated at the stage of 3-plus active disease (target serum E levels, 5-6 mg/dl) was evaluated by a standardized scoring system of visual morbidity at the one to two year eye exam among infants cared for in the University of Pennsylvania Neonatal Complex (1976-1978). The incidence of legal blindness in both eyes or worse was decreased from 71 to 40% in E Rx (n = 10) as compared to non-E Rx (n = 14) infants, and the number of infants with minimal visual morbidity was increased. Pilot studies (1972-76; target serum E level, 1.5 and 3.0 mg/dl) of the prophylactic effect of E Rx from birth on showed a decrease in mean severity of acute stage disease and a decrease in sequelae at one to two years. A strikingly difference in visual morbidity following resolved low-grade ROP was seen when prestudy infants (1968-72) who were fed early iron supplements and given formulas with low E:PUFA ratios were compared to non-E Rx as well as to E Rx 1972-76 infants. Vitamin E seems to exert a beneficial effect at all stages of ROP, perhaps because of its broadly based regulatory role.